Tenaya Therapeutics Ownership | Who Owns Tenaya Therapeutics?
Tenaya Therapeutics Ownership Summary
Tenaya Therapeutics is owned by 13.48% institutional investors, 0.47% insiders, and 86.05% retail investors. Column group is the largest institutional shareholder, holding 5.75% of TNYA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.98% of its assets in Tenaya Therapeutics shares.
TNYA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Tenaya Therapeutics | 13.48% | 0.47% | 86.05% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Column group | 9.40M | 5.75% | $6.69M |
| Vanguard group | 8.56M | 5.24% | $6.09M |
| Blackrock | 4.07M | 5.03% | $12.63M |
| Millennium management | 5.46M | 3.57% | $3.78M |
| Empery asset management, lp | 4.29M | 2.80% | $2.97M |
| Citadel advisors | 4.20M | 2.75% | $2.91M |
| Renaissance | 3.71M | 2.43% | $2.57M |
| Blackrock funding, inc. /de | 3.70M | 2.42% | $2.56M |
| Marshall wace, llp | 2.71M | 1.77% | $1.87M |
| Ghost tree capital | 1.35M | 1.67% | $4.18M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Column group | 9.40M | 8.08% | $6.69M |
| Empery asset management, lp | 4.29M | 3.58% | $2.97M |
| Ghost tree capital | 1.35M | 1.31% | $4.18M |
| Euclidean capital | 1.02M | 0.18% | $703.27K |
| Stepstone group lp | 462.16K | 0.15% | $318.89K |
| Diadema partners lp | 315.52K | 0.13% | $511.14K |
| Mirador capital partners lp | 886.92K | 0.09% | $614.10K |
| Persistent asset partners | 72.49K | 0.08% | $117.44K |
| Burkehill global management, lp | 2.00M | 0.07% | $1.38M |
| Castleview partners | 153.14K | 0.05% | $106.03K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 8.56M | 0.00% | 3.50M |
| Renaissance | 3.71M | 0.00% | 1.86M |
| Marshall wace, llp | 2.71M | 0.00% | 1.30M |
| Vanguard fiduciary trust | 1.02M | 0.00% | 1.02M |
| Millennium management | 5.46M | 0.00% | 840.92K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -6.98M |
| Woodline partners lp | - | - | -5.92M |
| Anson funds management lp | - | - | -4.15M |
| Alyeska investment group | - | - | -4.00M |
| Octagon capital advisors lp | - | - | -2.58M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 1.02M | 0.00% | 1.02M | $702.87K |
| Diadema partners lp | 315.52K | 0.13% | 315.52K | $511.14K |
| Acadian asset management | 169.78K | 0.00% | 169.78K | $116.00K |
| Castleview partners | 153.14K | 0.05% | 153.14K | $106.03K |
| Invesco | 138.01K | - | 138.01K | $95.56K |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -12.00 |
| Srs capital advisors | -60.00 |
| Clearstead advisors | -82.00 |
| Jones financial companies lllp | -100.00 |
| Rise advisors | -485.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 53 | -48.54% | 20,618,246 | -69.91% | 13 | 0.77% | 30 | -47.37% | 7 | -65.00% |
| Dec 31, 2025 | 68 | -27.66% | 45,507,062 | 31.79% | 27 | 6.19% | 37 | 8.82% | 15 | -53.13% |
| Sep 30, 2025 | 91 | - | 34,496,870 | 9.27% | 21 | 5.63% | 34 | -24.44% | 31 | 29.17% |
| Jun 30, 2025 | 91 | -14.95% | 31,571,278 | -34.46% | 19 | 1.01% | 44 | -16.98% | 25 | -21.88% |
| Mar 31, 2025 | 2 | -97.70% | 32,748 | -99.92% | - | 0.00% | 1 | -97.92% | 1 | -94.74% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 6.48M | 2.98% | - |
| US Small-Cap Growth II Equity Comp | 2.10M | 2.66% | -471.71K |
| T. Rowe Price New Horizons | 2.10M | 2.65% | -441.00 |
| Fidelity Select Biotechnology | 1.75M | 2.20% | - |
| JPMorgan US Small Company L | 785.69K | 0.91% | -315.70K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.77M | 0.82% | - |
| T. Rowe Price New Horizons Tr-Z | 554.73K | 0.70% | 9.11K |
| iShares Biotechnology ETF | 1.18M | 0.55% | 7.48K |
| Raiffeisen-Health&Wellbeing-ESG Akt A | 1.00M | 0.46% | - |
| Fidelity Small Cap Index | 608.02K | 0.37% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 18, 2026 | Ali Faraz | Chief Executive Officer | Sell | $2.69K |
| May 18, 2026 | Tingley Whittemore | Chief Medical Officer | Sell | $2.48K |
| May 18, 2026 | Higa Tomohiro | SVP, Finance | Sell | $1.18K |
| Feb 24, 2026 | COLUMN GROUP III GP, LP | - | Sell | $190.27K |
| Feb 24, 2026 | COLUMN GROUP III GP, LP | - | Sell | $214.87K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 3 |
| 2026 Q1 | - | 20 |
| 2025 Q4 | - | 3 |
| 2025 Q3 | - | 9 |
| 2025 Q2 | - | 3 |
TNYA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools